Sarbani Chaudhuri
Fortune : 914 884 $ au 30/06/2026
Fortune : 914 884 $ au 30/06/2026
Sarbani Chaudhuri is currently Chief Commercial & Medical Affairs Officer at Rocket Pharmaceuticals, Inc. since 2025.
Former positions include Vice President at Johnson & Johnson from 2022 to 2025 and Principal at AstraZeneca, Inc. from 2020 to 2021.
Education includes an MBA from the University of Pennsylvania, graduate studies at Xavier School of Management, and undergraduate studies at Veermata Jijabai Technological Institute.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/05/2026 | 267 510 ( 0,24% ) | 914 884 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 07/04/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/03/2025 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | 01/11/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veermata Jijabai Technological Institute
Veermata Jijabai Technological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xavier School of Management
Xavier School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national